207 related articles for article (PubMed ID: 7530020)
1. Buried surface analysis of HIV-1 reverse transcriptase p66/p51 heterodimer and its interaction with dsDNA template/primer.
Ding J; Jacobo-Molina A; Tantillo C; Lu X; Nanni RG; Arnold E
J Mol Recognit; 1994 Jun; 7(2):157-61. PubMed ID: 7530020
[TBL] [Abstract][Full Text] [Related]
2. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.
Ding J; Das K; Hsiou Y; Sarafianos SG; Clark AD; Jacobo-Molina A; Tantillo C; Hughes SH; Arnold E
J Mol Biol; 1998 Dec; 284(4):1095-111. PubMed ID: 9837729
[TBL] [Abstract][Full Text] [Related]
3. The p51 subunit of human immunodeficiency virus type 1 reverse transcriptase is essential in loading the p66 subunit on the template primer.
Harris D; Lee R; Misra HS; Pandey PK; Pandey VN
Biochemistry; 1998 Apr; 37(17):5903-8. PubMed ID: 9558323
[TBL] [Abstract][Full Text] [Related]
4. Collective motions in HIV-1 reverse transcriptase: examination of flexibility and enzyme function.
Bahar I; Erman B; Jernigan RL; Atilgan AR; Covell DG
J Mol Biol; 1999 Jan; 285(3):1023-37. PubMed ID: 9887265
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer.
Wang J; Smerdon SJ; Jäger J; Kohlstaedt LA; Rice PA; Friedman JM; Steitz TA
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7242-6. PubMed ID: 7518928
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the polymerization kinetics of homodimeric EIAV p51/51 reverse transcriptase implies the formation of a polymerase active site identical to heterodimeric EIAV p66/51 reverse transcriptase.
Souquet M; Restle T; Krebs R; Le Grice SF; Goody RS; Wöhrl BM
Biochemistry; 1998 Sep; 37(35):12144-52. PubMed ID: 9724526
[TBL] [Abstract][Full Text] [Related]
8. Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization.
Ghosh M; Jacques PS; Rodgers DW; Ottman M; Darlix JL; Le Grice SF
Biochemistry; 1996 Jul; 35(26):8553-62. PubMed ID: 8679616
[TBL] [Abstract][Full Text] [Related]
9. Protein-nucleic acid interactions and DNA conformation in a complex of human immunodeficiency virus type 1 reverse transcriptase with a double-stranded DNA template-primer.
Ding J; Hughes SH; Arnold E
Biopolymers; 1997; 44(2):125-38. PubMed ID: 9354757
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 reverse transcriptase interaction with model RNA-DNA duplexes.
Gorshkova II; Rausch JW; Le Grice SF; Crouch RJ
Anal Biochem; 2001 Apr; 291(2):198-206. PubMed ID: 11401293
[TBL] [Abstract][Full Text] [Related]
11. Relationship between enzyme activity and dimeric structure of recombinant HIV-1 reverse transcriptase.
Tachedjian G; Radzio J; Sluis-Cremer N
Proteins; 2005 Jul; 60(1):5-13. PubMed ID: 15852304
[TBL] [Abstract][Full Text] [Related]
12. A full-coordinate model of the polymerase domain of HIV-1 reverse transcriptase and its interaction with a nucleic acid substrate.
Setlik RF; Meyer DJ; Shibata M; Roskwitalski R; Ornstein RL; Rein R
J Biomol Struct Dyn; 1994 Aug; 12(1):037-60. PubMed ID: 7531452
[TBL] [Abstract][Full Text] [Related]
13. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.
Auwerx J; Van Nieuwenhove J; Rodríguez-Barrios F; de Castro S; Velázquez S; Ceccherini-Silberstein F; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
FEBS Lett; 2005 Apr; 579(11):2294-300. PubMed ID: 15848161
[TBL] [Abstract][Full Text] [Related]
14. Cross-linking localization of a HIV-1 reverse transcriptase peptide involved in the binding of primer tRNALys3.
Dufour E; Reinbolt J; Castroviejo M; Ehresmann B; Litvak S; Tarrago-Litvak L; Andreola ML
J Mol Biol; 1999 Jan; 285(4):1339-46. PubMed ID: 9917377
[TBL] [Abstract][Full Text] [Related]
15. Identification of specific HIV-1 reverse transcriptase contacts to the viral RNA:tRNA complex by mass spectrometry and a primary amine selective reagent.
Kvaratskhelia M; Miller JT; Budihas SR; Pannell LK; Le Grice SF
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15988-93. PubMed ID: 12461175
[TBL] [Abstract][Full Text] [Related]
16. Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations.
Arnold E; Jacobo-Molina A; Nanni RG; Williams RL; Lu X; Ding J; Clark AD; Zhang A; Ferris AL; Clark P
Nature; 1992 May; 357(6373):85-9. PubMed ID: 1374166
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of HIV-1 reverse transcriptase having a 1:1 ratio of p66 and p51 subunits.
Stahlhut M; Li Y; Condra JH; Fu J; Gotlib L; Graham DJ; Olsen DB
Protein Expr Purif; 1994 Dec; 5(6):614-21. PubMed ID: 7532052
[TBL] [Abstract][Full Text] [Related]
18. Expression of polypeptides of human immunodeficiency virus-1 reverse transcriptase in Escherichia coli.
Becerra SP; Kumar A; Wilson SH
Protein Expr Purif; 1993 Jun; 4(3):187-99. PubMed ID: 7686063
[TBL] [Abstract][Full Text] [Related]
19. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
[TBL] [Abstract][Full Text] [Related]
20. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
Ji X; Klarmann GJ; Preston BD
Biochemistry; 1996 Jan; 35(1):132-43. PubMed ID: 8555166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
